RESEARCH ALERT-Intellipharmaceutics: Roth Capital raises price target
November 20, 2013 at 12:17 PM EST
Nov 20 (Reuters) - Intellipharmaceutics International Inc : * Roth Capital Partners raises price target to $7.50 from $6; rating buy For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/US For a summary of rating and price target changes on Canadian companies: Reuters Eikon users, click on Reuters 3000Xtra users, double-click Thomson ONE users, type in RT/RCH/C
